ACTU director granted 15,000 stock options
ACTUATE THERAPEUTICS, INC. director Martin H. Huber Jr. received a grant of stock options covering 15,000 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ACTUATE THERAPEUTICS, INC. director Martin H. Huber Jr. received a grant of stock options covering 15,000 shares of common stock. The options have an exercise price of $2.4200 per share and expire on May 21, 2036. According to the filing, these options will vest in full on the anniversary of the grant date. Following this award, the filing shows Huber holding 15,000 stock options directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options | 15,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. Options will vest in full on the anniversary of the grant date.
Key Figures
Key Terms
Stock Options financial
grant/award acquisition financial
exercise price financial
Common Stock financial
vest in full financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ACTU director Martin H. Huber Jr. report in this Form 4 for ACTU?
What is the exercise price of the stock options granted to the ACTU director?
When do the newly granted ACTU stock options vest for the director?
When do the ACTU stock options granted to Martin H. Huber Jr. expire?
How many stock options does the ACTU director hold after this reported grant?
Is this ACTU Form 4 transaction a market buy or sell of common stock?
AI-generated analysis. How Rhea-AI works. Not financial advice.